| Date | Form | Description | Docs | XBRL | Pages |
| 01/31/06 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
59 | |
| 01/17/06 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
3 | |
| 01/04/06 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/14/05 | 5 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/02/05 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/02/05 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 11/02/05 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 10/21/05 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/07/05 | DEF 14A | Definitive proxy statements |
|
17 | |
| 09/29/05 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
Read More...Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation
Read More...Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
Read More...